Clinical trial
A Prospective, Randomized, Multicenter, Self-controlled, Blinded Trial on the Efficacy and Safety of Poly-L-lactic Acid - SCULPTRA - for the Treatment of Corporal Skin Flaccidity.
NCT03225066 is registered in ClinicalTrials.gov with Galderma Brasil Ltda. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Multicenter, Self-controlled, Blinded Trial on the Efficacy and Safety of Poly-L-lactic Acid - SCULPTRA - for the Treatment of Corporal Skin Flaccidity.
- Lead sponsor
- Galderma Brasil Ltda.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 21, 2017
- Completion date
- January 10, 2018
- Enrollment
- 70 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
flaccidity, muscle